These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2054443)

  • 21. Lactation associated with fluoxetine treatment.
    Arya DK; Taylor WS
    Aust N Z J Psychiatry; 1995 Dec; 29(4):697. PubMed ID: 8825840
    [No Abstract]   [Full Text] [Related]  

  • 22. Contribution of trifluoperazine metabolites to the in vivo (19)F NMR spectrum of rat brain.
    Lindquist DM; Dachtler M; Hawk RM; Karson CN; Albert K; Komoroski RA
    Magn Reson Med; 2000 May; 43(5):756-9. PubMed ID: 10800042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fixed combination of chlorpromazine and trifluoperazine in psychotic patients.
    Swanson DW; Smith JA; Perez H
    Dis Nerv Syst; 1967 Nov; 28(11):756. PubMed ID: 4863821
    [No Abstract]   [Full Text] [Related]  

  • 24. Trifluoperazine and chlorpromazine in combination and individually.
    Gardos G; Rapkin RM; DiMascio A
    Curr Ther Res Clin Exp; 1968 Dec; 10(12):609-12. PubMed ID: 4972755
    [No Abstract]   [Full Text] [Related]  

  • 25. Fluoxetine and neuroleptic malignant syndrome.
    Halman M; Goldbloom DS
    Biol Psychiatry; 1990 Sep; 28(6):518-21. PubMed ID: 2223920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders.
    Regenold WT; Phatak P; Kling MA; Hauser P
    Mol Psychiatry; 2004 Aug; 9(8):731-3. PubMed ID: 15098005
    [No Abstract]   [Full Text] [Related]  

  • 27. A double-blind comparison of the onset of activity of haloperidol and trifluoperazine.
    Rubin R
    Ala J Med Sci; 1971 Oct; 8(4):414-8. PubMed ID: 4945243
    [No Abstract]   [Full Text] [Related]  

  • 28. Water, water, everywhere, nor any drop to drink: climate change delusion.
    Wolf J; Salo R
    Aust N Z J Psychiatry; 2008 Apr; 42(4):350. PubMed ID: 18330779
    [No Abstract]   [Full Text] [Related]  

  • 29. Improvement of tinnitus with trifluoperazine in a patient with psychosis and ear disease.
    Jain S; Srivastava AS; Madhu ; Maggu G; Pandey M
    Asian J Psychiatr; 2017 Dec; 30():177-178. PubMed ID: 29080514
    [No Abstract]   [Full Text] [Related]  

  • 30. Haloperidol in controlling the symptoms of acute psychoses. II. A double-blind evaluation of haloperidol and trifluoperazine.
    Goldstein BJ; Clyde DJ
    Curr Ther Res Clin Exp; 1966 May; 8(5):236-40. PubMed ID: 4956549
    [No Abstract]   [Full Text] [Related]  

  • 31. [Management of psychotic drive disorders].
    Langner E
    Wien Med Wochenschr; 1968 Sep; 118(36):700-2. PubMed ID: 5679053
    [No Abstract]   [Full Text] [Related]  

  • 32. [Electroencephalographic study of changes in the functional state of the brain in mental patients during stelazine therapy].
    Kopylova TV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(8):1229-31. PubMed ID: 5700591
    [No Abstract]   [Full Text] [Related]  

  • 33. Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports.
    Jalil P
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):412-3. PubMed ID: 1602320
    [No Abstract]   [Full Text] [Related]  

  • 34. Brain bioenergetics and redox state measured by
    Chouinard VA; Kim SY; Valeri L; Yuksel C; Ryan KP; Chouinard G; Cohen BM; Du F; Öngür D
    Schizophr Res; 2017 Sep; 187():11-16. PubMed ID: 28258794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of metabolic interaction: amitriptyline, fluoxetine, antitubercular agents].
    Bertschy G; Vandel S; Perault MC
    Therapie; 1994; 49(6):509-12. PubMed ID: 7878612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "There is nothing in this world can make me joy". Fluoxetine (Prozac) poisoning.
    Mack RB
    N C Med J; 1994 Aug; 55(8):358-60. PubMed ID: 7935885
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of triphthazine in the treatment of mentae disorders].
    Gurowitsch IJ; Awruzki GJ
    Psychiatr Neurol Med Psychol (Leipz); 1975 May; 27(5):284-91. PubMed ID: 812131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.
    Sonawalla SB; Renshaw PF; Moore CM; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    Am J Psychiatry; 1999 Oct; 156(10):1638-40. PubMed ID: 10518178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some recent applications of 1H NMR spectroscopy in vivo.
    Gadian DG; Proctor E; Williams SR
    Ann N Y Acad Sci; 1987; 508():241-50. PubMed ID: 3439704
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.
    Beasley CM; Bosomworth JC; Wernicke JF
    Psychopharmacol Bull; 1990; 26(1):18-24. PubMed ID: 2196623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.